Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ezra E Cohen Everett E Vokes Daniel Haber Mark W. Lingen |
| Publication date | November 1, 2005 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |